HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Hauswirth et al. Supplementary Appendix Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hauswirth, A. W. Articles by Jäger, U. Search for Related Content PubMed PubMed Citation Articles by Hauswirth, A. W. Articles by Jäger, U.

Autoimmune thrombocytopenia in non-Hodgkin’s lymphomas

¹ Department of Medicine I, Division of Hematology and Hemostaseology and
² Oncology
³ Department of Pathology, Medical University of Vienna, Vienna, Austria

Correspondence: Alexander Hauswirth, Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, A 1090 Währingergürtel 18– 20, Austria. E-mail: alexander.hauswirth{at}meduniwien.ac.at

Autoimmune thrombocytopenia is a common immunehematologic complication in non-Hodgkin’s lymphomas and may complicate the treatment. We analyzed an original series from our institute as well as published cases of non-Hodgkin’s lymphomas (excluding chronic lymphocytic leukemia) associated with autoimmune thrombocytopenia with regard to demographic factors, prevalence in non-Hodgkin’s lymphoma subtypes and treatment outcome. The male/female ratio is 1.75. Half of the cases occurred prior to diagnosis of lymphoma. Chemotherapy is the best treatment in many non-Hodgkin’s lymphomas patients with autoimmune thrombocytopenia compared with standard treatment of autoimmune thrombocytopenia. Splenectomy is effective in splenic marginal zone lymphoma. Autoimmune thrombocytopenia in patients with non-Hodgkin’s lymphomas is potentially life-threatening and difficult to treat.

Key words: autoimmune thrombocytopenias, non-Hodgkin’s lymphoma.

This article has been cited by other articles:

				D. B. Cines, J. B. Bussel, H. A. Liebman, and E. T. Luning Prak The ITP syndrome: pathogenic and clinical diversity Blood, June 25, 2009; 113(26): 6511 - 6521. [Abstract] [Full Text] [PDF]